TWIST1 and breast carcinoma: Because some cancer cells do not have TWIST1/N-cadherin signaling, such as prostatic cancer LNCaP cells or breast cancer MCF-7 cells, we wished to determine whether molecular mechanism of metformin's action in these N-cadherin deficiency cancer cells.